Frequency of occurrence of HIV-1 dual infection in a Belgian MSM population

PLoS One. 2018 Apr 6;13(4):e0195679. doi: 10.1371/journal.pone.0195679. eCollection 2018.

Abstract

Introduction: HIV-1 dual infection is a condition that results from infection with at least two HIV-1 variants from different sources. The scarceness of information on this condition is partly due to the fact that its detection is technically challenging. Using next-generation sequencing we defined the extent of HIV-1 dual infection in a cohort of men who have sex with men (MSM).

Material & methods: Eighty-six MSM, diagnosed with HIV-1 subtype B infection between 2008 and 2013 were selected for next-generation sequencing of the HIV-1 envelope V3. Sequencing was performed on 2 plasma samples collected with an interval of > 6 months before the initiation of antiretroviral therapy. Maximum likelihood phylogenetic trees were inspected for dual infection, defined as the presence of two or more monophyletic clusters with ≥ 90% bootstrap support and a mean between-cluster genetic distance of ≥ 10%. To confirm dual infection, deep V3 sequencing of intermediate samples was performed as well as clonal sequencing of the HIV-1 protease-reverse transcriptase gene.

Results: Five of the 74 patients (6.8%) for whom deep sequencing was successful, showed clear evidence of dual infection. In 4 of them, the second strain was absent in the first sample but occurred in subsequent samples. This was highly suggestive for superinfection. In 3 patients both virus variants were of subtype B, in 2 patients at least one of the variants was a subtype B/non-B recombinant virus.

Conclusions: Dual infection was confirmed in 6.8% of MSM diagnosed with HIV-1 in Belgium. This prevalence is probably an underestimation, because stringent criteria were used to classify viral variants as originating from a new infection event.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Belgium / epidemiology
  • HIV Envelope Protein gp120 / genetics
  • HIV Infections / epidemiology*
  • HIV Infections / virology
  • HIV-1* / classification
  • HIV-1* / genetics
  • High-Throughput Nucleotide Sequencing
  • Homosexuality, Male
  • Humans
  • Male
  • Middle Aged
  • Peptide Fragments / genetics
  • Phylogeny
  • Prevalence
  • Pyrroles
  • Retrospective Studies
  • Superinfection / epidemiology
  • Superinfection / virology

Substances

  • HIV Envelope Protein gp120
  • HIV envelope protein gp120 (305-321)
  • Peptide Fragments
  • Pyrroles
  • alpha-(4-(5-((2-carboxy)phenyl)-5-hydroxy-4-oxo-3-phenyl-2-pyrrolin-1-yl)phenyl)-N-(tert-butyl)nitrone

Grants and funding

The AIDS Reference Laboratory of Ghent is supported by the Belgian Ministery of Social Affairs through a fund within the Health Insurance System. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.